Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1317702rdf:typepubmed:Citationlld:pubmed
pubmed-article:1317702lifeskim:mentionsumls-concept:C0026549lld:lifeskim
pubmed-article:1317702lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:1317702lifeskim:mentionsumls-concept:C0008405lld:lifeskim
pubmed-article:1317702lifeskim:mentionsumls-concept:C1959616lld:lifeskim
pubmed-article:1317702lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:1317702lifeskim:mentionsumls-concept:C0243126lld:lifeskim
pubmed-article:1317702pubmed:issue1lld:pubmed
pubmed-article:1317702pubmed:dateCreated1992-6-26lld:pubmed
pubmed-article:1317702pubmed:abstractTextCalcium (25 mM)-stimulated incorporation of choline into phosphatidylcholine (PC) and 3H-morphine (3H-M) binding was studied using cerebral crude synaptosomal fractions from acute morphine-treated (naive), morphine-dependent and morphine-withdrawn mice. Mice became physically dependent on morphine after ingesting morphine-mixed food. Morphine dependence inhibited the incorporation of 14C-choline into PC. The injection of naloxone (1 mg/kg) to morphine-dependent mice also inhibited the incorporation of 14C-choline into PC. The injection of morphine (10 mg/kg) to morphine-withdrawn mice stimulated the incorporation of 14C-choline into PC, but had no effect, either on acute morphine-treated mice or on morphine-dependent mice. Naloxone (1 mg/kg), morphine (10 mg/kg), morphine dependence and opiate withdrawal (20 hrs after the last exposure to morphine in food) all caused about a 25% decrease in 3H-M (10(-7) M) binding to mouse brain synaptosomes. The injection of 10 mg/kg of morphine 45 min before death caused an additional 20% decrease in 3H-morphine binding in the dependent and withdrawn mice, but not in the naive mice. Stereospecific binding (SSB) of 3H-M was evaluated with respect to: 1) the effect of naloxone treatment in vivo on 3H-M binding in vitro, 2) the effect of morphine treatment in vivo on 3H-M binding in vitro; and 3) the differences between 3H-M bound (in vitro) and both naloxone and morphine treatment (in vivo). SSB activity was high in morphine-withdrawn mice. These differences may be caused by changes in the opiate receptors related to tolerance and withdrawal, and may entail between PC and membrane receptors.lld:pubmed
pubmed-article:1317702pubmed:languageenglld:pubmed
pubmed-article:1317702pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1317702pubmed:citationSubsetIMlld:pubmed
pubmed-article:1317702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1317702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1317702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1317702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1317702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1317702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1317702pubmed:statusMEDLINElld:pubmed
pubmed-article:1317702pubmed:monthFeblld:pubmed
pubmed-article:1317702pubmed:issn0389-4118lld:pubmed
pubmed-article:1317702pubmed:authorpubmed-author:NatsukiRRlld:pubmed
pubmed-article:1317702pubmed:issnTypePrintlld:pubmed
pubmed-article:1317702pubmed:volume27lld:pubmed
pubmed-article:1317702pubmed:ownerNLMlld:pubmed
pubmed-article:1317702pubmed:authorsCompleteYlld:pubmed
pubmed-article:1317702pubmed:pagination57-70lld:pubmed
pubmed-article:1317702pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:meshHeadingpubmed-meshheading:1317702-...lld:pubmed
pubmed-article:1317702pubmed:year1992lld:pubmed
pubmed-article:1317702pubmed:articleTitleRelationship between incorporation of choline into phosphatidylcholine and morphine binding sites.lld:pubmed
pubmed-article:1317702pubmed:affiliationFaculty of Pharmaceutical Sciences, Setsunan University.lld:pubmed
pubmed-article:1317702pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1317702pubmed:publicationTypeIn Vitrolld:pubmed